Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

NCT00019409 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Leukemia

Interventions

DRUG: asparaginase
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: mercaptopurine
DRUG: methotrexate
DRUG: prednisone
DRUG: therapeutic hydrocortisone
DRUG: vincristine sulfate
RADIATION: radiation therapy

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]